Table 1.
Adipokines | Functions | Tendency in obesity | Inducers | Effects on HCC | Molecular mechanisms | References |
---|---|---|---|---|---|---|
Anti-inflammatory | ||||||
Adiponectin | Increases insulin sensitivity Relieves inflammation Eliminates HCC cells |
Downregulated | Insulin resistance Hypoxia microenvironment Chronic inflammation |
Inhibits | AMPK/TSC2/mTOR↑, Caspase-3↑, JNK↑, STAT3↓, PI3K/Akt↓, SOCS3↑, TNF-α↓. |
(20–22, 24–29) |
Ghrelin | Regulates energy steady state Maintains healthy liver function Reduces lipid toxicity |
Downregulated | Insulin resistance Positive energy balance |
Inhibits | NF-ĸB↓, TNF-α↓, TG↓. | (30–33) |
Irisin | Improves glucose homeostasis Improves insulin resistance Induces weight loss |
Downregulated | Lack of exercise T2D |
Inhibits | De novo lipogenesis↓ | (31, 34, 35) |
Pro-inflammatory | ||||||
Leptin | Regulates the appetite and energy balance Resists weight gain Promotes hepatic steatosis |
Upregulated | Lipotrophy Chronic inflammation |
Promotes | JAK2/STAT3↑, PI3K/Akt↑, ERK↑, p53/FOXO3A↑ | (24, 28, 36, 37) |
Resistin | Antagonizes insulin Induces hepatic insulin resistance |
Upregulated | Insulin resistance Central/visceral obesity |
Promotes | p38 MAPK/NF-κB↑ | (38–41) |
Visfatin | Exerts insulin-like hypoglycemic effect Promotes adipose expansion Hepatic inflammation |
Upregulated | Insulin resistance | Promotes | NF-ĸB↑, STAT3↑, PI3K/Akt↑, ERK↑ | (31, 42–47) |